Litcius/Paper detail

Piperacillin/tazobactam vs. cefepime or carbapenems for the treatment of bloodstream infections due to bacteria producing chromosomal AmpC beta-lactamase: a systematic review and meta-analysis

Lorenzo Onorato, Ilaria de Luca, Annabella Salvati, Caterina Monari, Nicola Coppola

2024Infection13 citationsDOI

Topics & Concepts

CefepimeMedicinePiperacillin/tazobactamTazobactamPiperacillinInternal medicineCochrane LibraryMeta-analysisIntensive care medicineAntibioticsMicrobiologyAntibiotic resistanceBiologyImipenemBacteriaGeneticsPseudomonas aeruginosaAntibiotic Resistance in BacteriaAntibiotics Pharmacokinetics and EfficacyNeutropenia and Cancer Infections
Piperacillin/tazobactam vs. cefepime or carbapenems for the treatment of bloodstream infections due to bacteria producing chromosomal AmpC beta-lactamase: a systematic review and meta-analysis | Litcius